EPO ruling clarifies appeal rights, blocking third-party intervention

A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Jury sides with Allergan in $56M Botox tech feud

22 July 2025 $56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues.

Europe

La Prairie accused of stealing caviar biotech for luxury skincare line

4 March 2025 UK biotech firm accuses luxury skincare brand La Prairie of misappropriating proprietary research on caviar-derived ingredients | Lawsuit claims La Prairie lacked expertise to develop the tech before accessing confidential trade secrets.

Big Pharma

Swiss watchdog investigates Novartis over patent use

20 September 2022 Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition

More features

Womble Bond Dickinson partners jump to rival firm

Biotech sues AstraZeneca and Cellectis over mRNA patents

Trump threatens 100% tariff hike on pharma imports into the US

Budgets, CRISPR, and keeping pace with tech: top challenges for Europe’s patent pros

EU court delivers verdict on Biogen’s market exclusivity for MS drug

Mewburn expands AI and medtech expertise with London hire

AbbVie faces secrets lawsuit over $2.1bn Capstan deal

All eyes on Squires: What IP experts want from the new USPTO director

EPO ruling clarifies appeal rights, blocking third-party intervention

More on this story

Editor's picks

Editor's picks

More features